Sodium taurocholate

SKU: orb1296054

Description

Sodium taurocholate is a research compound used to model experimental pancreatitis. It demonstrates hepatoprotective properties by upregulating VEGF-A to mitigate bile duct injury, and it exhibits immunomodulatory effects, supporting its use in both in vivo and in vitro gastrointestinal disease studies.

Key Properties

• CAS Number: 145-42-6
• MW: 537.69
• Purity: 95.00% (May vary between batches)
• Formula: C₂₆H₄₄NO₇S.Na
• SMILES: [Na+].C[C@H](CCC(=O)NCCS([O-])(=O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)CC4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C
• Target: Others
• Solubility: H2O:53.76 mg/mL (99.98 mM);DMSO:176.4 mg/mL (328.07 mM);10% DMSO+40% PEG300+5% Tween 80+45% Saline:2.5 mg/mL (4.65 mM)

Storage & Handling

• Storage: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

I nterleukin-1β, Inhibitor, hepatic artery, Endogenous Metabolite, inhibit, Immunoregulation, N-Choloyltaurine, CD4+/CD8+, Sodium taurocholate, Sodium taurocholate hydrate, Taurocholate Sodium, Taurocholic acid, VEGF-A expression, VEGFR, Vascular endothelial growth factor receptor, Tumor necrosis factor-α

Compound Identifiers

PubChem CID

23671686